Quality Control in the Radiopharmacy

Abstract

This is the first of a series of four continuing education articles on radiopharmaceuticals. (This topic was developed in response to the results of the Journal’s 1983 reader survey.) The radiopharmaceutical series will discuss quality control in the radiopharmacy, development of new radiopharmaceuticals and their applications, including gold-195m and iodine-123 amphetamines, preparation and imaging of indium-III-labeled leukocytes, and radiopharmaceuticals for renal imaging. After reading and studying this article, the nuclear medicine technologist will be familiar with NRC and USPNF regulations that apply to the radiopharmacy, and able to review the radiopharmacy quality control program at his or her institution to insure compliance.